project id: TCGA-BLCA; case submitter id: TCGA-DK-AA76; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 2.29; rna integrity number: 9.5; age at index: 64; days to birth: -23542; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 23542; ajcc clinical t: T2; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 366.0; icd 10 code: C67.3; last known disease status: not reported; morphology: 8120/3; primary diagnosis: Transitional cell carcinoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Anterior wall of bladder; synchronous malignancy: No; tissue or organ of origin: Anterior wall of bladder; tumor grade: Not Reported; year of diagnosis: 2013; alcohol history: Not Reported; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; is ffpe: false; composition: Not Reported; days to collection: 216; initial weight: 380.0; sample id: e98b7d82-0274-4fbe-829b-552552799ad9; sample submitter id: TCGA-DK-AA76-01A; portion id: f8acf225-dd07-4eb2-9c77-ecd3a0d3738a; portion submitter id: TCGA-DK-AA76-01A-11; slide id: 6f343dde-2751-4a7d-a0c3-8187e0bf4c6d; slide submitter id: TCGA-DK-AA76-01A-01-TSA; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 60.0; section location: TOP;